TW Research Group | Micro-Cap Stock Ideas

3 Dot Lounge…

Daniel Carlson - March 25, 2023

When I moved to San Francisco in 1989, Herb Caen was a renowned columnist for the San Francisco Chronicle. His was an unabashed lover...

Movano Health Provides Business Update and Reports Fourth Quarter 2022 Financial Results

Daniel Carlson - March 20, 2023

TW's Take: we greatly look forward to the results from the glucose monitoring tests that are due to start "imminently". PLEASANTON, Calif., March 20, 2023 /PRNewswire/ --...

Upcoming Catalysts (or, Meaningful Events That Probably Won’t Help Your Portfolio)

Daniel Carlson - March 18, 2023

How do you know when you're in a bear market? The simplest answer is this, All News Is Bad. When a company puts out...

March 17, 2023 Trade Update

Daniel Carlson - March 17, 2023

~ This article is available for premium subscribers only. Please do not share the information here with non-premium subscribers or with company managements. Thank...

IN8bio to Present Positive Preclinical Data on Novel Gamma-Delta CAR Platform at AACR Annual...

Daniel Carlson - March 16, 2023

TW's Take: yet more very positive data from INAB. As more patients get dosed in trials, this is setting up to be a very...

Movano Health Awarded Three New Core Patents Validating its Cutting-Edge Approach to Radio Frequency-Enabled...

Daniel Carlson - March 14, 2023

TW's Take: the key line from this PR is that the SoC is being tested on patients in this current month of March. Those...

Premium Subscriber Update SPVNF, March 14th

Daniel Carlson - March 14, 2023

~ This article is available for premium subscribers only. Please do not share the information here with non-premium subscribers or with company managements. Thank...

Spectra7 Announces 112G PAM4 Design-In with Zhaolong for North American and China Data Center...

Daniel Carlson - March 13, 2023

TW's Take: there is definite interest in S7's technology in the next generation of data center designs. We look forward to seeing this translate...

Black Swan Diving

Daniel Carlson - March 11, 2023

Funding just got tougher. My frequent description of TW's universe is that of "public venture capital". Our stocks share many of similarities with those companies...

Spectra7 Microsystems Inc. Announces Private Placement of $5.89 Million CAD

Daniel Carlson - March 10, 2023

TW's Take: This is very positive as it removes the financing overhang and positions the company for a high-growth phase that it anticipates entering...

Lantern Pharma to Host Virtual KOL Webinar on Synthetic Lethality, the Powerful Mechanism of...

Daniel Carlson - March 8, 2023

TW's Take: excited for this call as I have long felt that Lantern's LP-184 has billion dollar potential. DALLAS--(BUSINESS WIRE)-- Lantern Pharma Inc. (NASDAQ: LTRN),...

What Women Want: Accuracy is Critical to Future Wearable Use

Daniel Carlson - March 7, 2023

TW's Take: Movano is positioning themselves well in this market with potentially best in class performance and FDA approval driving adoption. PLEASANTON, Calif., March 7, 2023 /PRNewswire/...

INmune Bio: Things Turning For The Better

Daniel Carlson - March 4, 2023

This past week was a surprisingly great week in TW's universe. I say surprisingly as, after watching INmune Bio (INMB) take a morning bath...

Premium Subscriber Update INMB, TFFP, SPVNF & BWLKF

Daniel Carlson - March 3, 2023

~ This article is available for premium subscribers only. Please do not share the information here with non-premium subscribers or with company managements. Thank...

Lantern Pharma Expands Clinical Leadership Team to Further Advance its Ongoing and Upcoming Clinical...

Daniel Carlson - March 2, 2023

TW's Take: Lantern is positioning themselves for success in clinical trials. Once they get rolling, the market should start to pay attention. DALLAS--(BUSINESS WIRE)-- Lantern...

Lantern Pharma and TTC Oncology Establish AI Collaboration to Expand the Clinical Development of...

Daniel Carlson - February 27, 2023

TW's Take: this is a positive step but we would like to see many more of these, creating a portfolio of partnering opportunities around...

Anixa Biosciences Announces Notice of Allowance of Additional Key Patent on Breast Cancer Vaccine...

Daniel Carlson - February 27, 2023

TW's Take: all systems go for the vaccine as we await key data in April that should be the catalyst for shares of ANIX. SAN...

Market Tests Support…Here’s What To Do.

Daniel Carlson - February 25, 2023

In the last two newsletters, I have been saying that the markets looked ready to move lower. More exactly, two weeks ago I said...

Trade Alert for Premium Subscribers, Feb. 23 2023

Daniel Carlson - February 23, 2023

~ This article is available for premium subscribers only. Please do not share the information here with non-premium subscribers or with company managements. Thank...

IN8bio Presents Preclinical Data Showing Non-Signaling CAR Platform Targets Cancer Cells While Preserving Healthy...

Daniel Carlson - February 23, 2023

TW's Take: Exciting data that should help drive important partnering conversations for INAB with potential large pharma partners. NEW YORK, Feb. 23, 2023 (GLOBE NEWSWIRE)...

Receive Our Weekly Newsletter

Every Sunday we recap the market and consolidate the news from our universe. It’s free to subscribe. Just click on the link below.

Newsletter Signup

Premium Membership

For those interested in doing a deeper dive into our coverage universe, we offer premium membership. Benefits of being a premium member include the following:

First Look: new names added to the portfolio, or stocks being removed, are shared with premium subscribers before anyone else.

Trade Alerts: when actionable events occur, we highlight the opportunities in an email to our premium subscribers

TW Private Chat Room: premium members have access to our exclusive chat room where more research and ideas are freely shared amongst the whole community.

SIGN ME UP

Home